{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:35:17Z","timestamp":1793496917548,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04330-1","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:49:55Z","timestamp":1753879795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An auxiliary diagnostic strategy for distinguishing Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: combining platelet-to-lymphocyte ratio and cerebrospinal fluid interleukin-8 levels"],"prefix":"10.1186","volume":"25","author":[{"given":"Simin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianru","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinzhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"4","key":"4330_CR1","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","volume":"18","author":"L Querol","year":"2021","unstructured":"Querol L, Lleix\u00e0 C. Novel immunological and therapeutic insights in Guillain-Barr\u00e9 syndrome and CIDP. Neurotherapeutics Oct. 2021;18(4):2222\u201335. https:\/\/doi.org\/10.1007\/s13311-021-01117-3.","journal-title":"Neurotherapeutics Oct"},{"issue":"8","key":"4330_CR2","doi-asserted-by":"publisher","first-page":"e16365","DOI":"10.1111\/ene.16365","volume":"31","author":"R Bellanti","year":"2024","unstructured":"Bellanti R, Rinaldi S. Guillain-Barr\u00e9 syndrome: a comprehensive review. Eur J Neurol Aug. 2024;31(8):e16365. https:\/\/doi.org\/10.1111\/ene.16365.","journal-title":"Eur J Neurol Aug"},{"issue":"12","key":"4330_CR3","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/ene.16073","volume":"30","author":"PA van Doorn","year":"2023","unstructured":"van Doorn PA, Van den Bergh PYK, Hadden RDM, et al. European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome. Eur J Neurol Dec. 2023;30(12):3646\u201374. https:\/\/doi.org\/10.1111\/ene.16073.","journal-title":"Eur J Neurol Dec"},{"issue":"8","key":"4330_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1515\/revneuro-2023-0024","volume":"15","author":"Y Song","year":"2023","unstructured":"Song Y, Zheng X, Fang Y, et al. Current status of Guillain-Barr\u00e9 syndrome (GBS) in china: a 10-year comprehensive overview. Rev Neurosci Dec. 2023;15(8):869\u201397. https:\/\/doi.org\/10.1515\/revneuro-2023-0024.","journal-title":"Rev Neurosci Dec"},{"issue":"11","key":"4330_CR5","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task Force-Second revision. Eur J Neurol Nov. 2021;28(11):3556\u201383. https:\/\/doi.org\/10.1111\/ene.14959.","journal-title":"Eur J Neurol Nov"},{"issue":"9","key":"4330_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","volume":"90","author":"HC Lehmann","year":"2019","unstructured":"Lehmann HC, Burke D, Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, Immunopathogenesis and treatment. J Neurol Neurosurg Psychiatry Sep. 2019;90(9):981\u20137. https:\/\/doi.org\/10.1136\/jnnp-2019-320314.","journal-title":"J Neurol Neurosurg Psychiatry Sep"},{"issue":"5","key":"4330_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/wco.0000000000000481","volume":"30","author":"RA Lewis","year":"2017","unstructured":"Lewis RA. Chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol Oct. 2017;30(5):508\u201312. https:\/\/doi.org\/10.1097\/wco.0000000000000481.","journal-title":"Curr Opin Neurol Oct"},{"key":"4330_CR8","doi-asserted-by":"publisher","unstructured":"Zinellu A, Zinellu E, Mangoni AA, et al. Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future. Eur Respir Rev Dec. 2022;31(166). https:\/\/doi.org\/10.1183\/16000617.0095-2022.","DOI":"10.1183\/16000617.0095-2022"},{"key":"4330_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jocn.2021.04.013","volume":"89","author":"X Li","year":"2021","unstructured":"Li X, Wu F, Jiang C, et al. Novel peripheral blood cell ratios: effective 3-month post-mechanical thrombectomy prognostic biomarkers for acute ischemic stroke patients. J Clin Neurosci Jul. 2021;89:56\u201364. https:\/\/doi.org\/10.1016\/j.jocn.2021.04.013.","journal-title":"J Clin Neurosci Jul"},{"issue":"10","key":"4330_CR10","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.3390\/curroncol29100591","volume":"7","author":"A Jalali","year":"2022","unstructured":"Jalali A, Miresse D, Fahey MR, et al. Peripheral blood cell ratios as prognostic indicators in a neoadjuvant Chemotherapy-Treated breast cancer cohort. Curr Oncol Oct. 2022;7(10):7512\u201323. https:\/\/doi.org\/10.3390\/curroncol29100591.","journal-title":"Curr Oncol Oct"},{"issue":"5","key":"4330_CR11","first-page":"3017","volume":"14","author":"P Li","year":"2022","unstructured":"Li P, Li H, Ding S, Zhou J, NLR. PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma. Am J Transl Res. 2022;14(5):3017\u201327.","journal-title":"Am J Transl Res"},{"issue":"6","key":"4330_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.21037\/tlcr.2019.11.16","volume":"8","author":"H Mandaliya","year":"2019","unstructured":"Mandaliya H, Jones M, Oldmeadow C, Nordman II. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res Dec. 2019;8(6):886\u201394. https:\/\/doi.org\/10.21037\/tlcr.2019.11.16.","journal-title":"Transl Lung Cancer Res Dec"},{"key":"4330_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3389\/fphar.2018.00886","volume":"9","author":"PF Wang","year":"2018","unstructured":"Wang PF, Meng Z, Song HW, et al. Preoperative changes in hematological markers and predictors of glioma grade and survival. Front Pharmacol. 2018;9:886. https:\/\/doi.org\/10.3389\/fphar.2018.00886.","journal-title":"Front Pharmacol"},{"key":"4330_CR14","doi-asserted-by":"publisher","first-page":"103507","DOI":"10.1016\/j.msard.2022.103507","volume":"58","author":"E Carnero Contentti","year":"2022","unstructured":"Carnero Contentti E, L\u00f3pez PA, Criniti J, et al. Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability. Mult Scler Relat Disord Feb. 2022;58:103507. https:\/\/doi.org\/10.1016\/j.msard.2022.103507.","journal-title":"Mult Scler Relat Disord Feb"},{"key":"4330_CR15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/ndt.S162896","volume":"14","author":"O Ethemoglu","year":"2018","unstructured":"Ethemoglu O, Calik M. Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barr\u00e9 syndrome. Neuropsychiatr Dis Treat. 2018;14:1255\u201360. https:\/\/doi.org\/10.2147\/ndt.S162896.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4330_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jocn.2022.08.017","volume":"105","author":"L Xu","year":"2022","unstructured":"Xu L, Gao TX, Chang SH, Jiang SM, Zhang LJ, Yang L. Role of lymphocyte-related immune-inflammatory biomarkers in detecting early progression of Guillain-Barr\u00e9 syndrome. J Clin Neurosci Nov. 2022;105:31\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2022.08.017.","journal-title":"J Clin Neurosci Nov"},{"key":"4330_CR17","doi-asserted-by":"publisher","first-page":"155828","DOI":"10.1016\/j.cyto.2022.155828","volume":"153","author":"K Matsushima","year":"2022","unstructured":"Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: an evolving chemokine. Cytokine May. 2022;153:155828. https:\/\/doi.org\/10.1016\/j.cyto.2022.155828.","journal-title":"Cytokine May"},{"key":"4330_CR18","doi-asserted-by":"publisher","unstructured":"Viloti\u0107 A, Nacka-Aleksi\u0107 M, Pirkovi\u0107 A, Boji\u0107-Trbojevi\u0107 \u017d, Dekanski D, Jovanovi\u0107 Krivoku\u0107a M. IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies. Int J Mol Sci Nov. 2022;23(23). https:\/\/doi.org\/10.3390\/ijms232314574.","DOI":"10.3390\/ijms232314574"},{"key":"4330_CR19","doi-asserted-by":"publisher","first-page":"107692","DOI":"10.1016\/j.pharmthera.2020.107692","volume":"219","author":"K Fousek","year":"2021","unstructured":"Fousek K, Horn LA, Palena C. Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacol Ther Mar. 2021;219:107692. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107692.","journal-title":"Pharmacol Ther Mar"},{"key":"4330_CR20","doi-asserted-by":"publisher","first-page":"636954","DOI":"10.3389\/fimmu.2021.636954","volume":"12","author":"D D\u00f6mer","year":"2021","unstructured":"D\u00f6mer D, Walther T, M\u00f6ller S, Behnen M, Laskay T. Neutrophil extracellular traps activate Proinflammatory functions of human neutrophils. Front Immunol. 2021;12:636954. https:\/\/doi.org\/10.3389\/fimmu.2021.636954.","journal-title":"Front Immunol"},{"issue":"1","key":"4330_CR21","doi-asserted-by":"publisher","first-page":"e16095","DOI":"10.1111\/ene.16095","volume":"31","author":"M Bruno","year":"2024","unstructured":"Bruno M, Bonomi CG, Ricci F, et al. Blood-brain barrier permeability is associated with different neuroinflammatory profiles in alzheimer\u2019s disease. Eur J Neurol Jan. 2024;31(1):e16095. https:\/\/doi.org\/10.1111\/ene.16095.","journal-title":"Eur J Neurol Jan"},{"key":"4330_CR22","doi-asserted-by":"publisher","unstructured":"Shkundin A, Halaris A. IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions. J Pers Med May. 2024;3(5). https:\/\/doi.org\/10.3390\/jpm14050488.","DOI":"10.3390\/jpm14050488"},{"issue":"6","key":"4330_CR23","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.28015","volume":"35","author":"RS Wijeyekoon","year":"2020","unstructured":"Wijeyekoon RS, Moore SF, Farrell K, Breen DP, Barker RA, Williams-Gray CH. Cerebrospinal fluid cytokines and Neurodegeneration-Associated proteins in parkinson\u2019s disease. Mov Disord Jun. 2020;35(6):1062\u20136. https:\/\/doi.org\/10.1002\/mds.28015.","journal-title":"Mov Disord Jun"},{"key":"4330_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2017.03.007","volume":"14","author":"Z Matej\u010d\u00edkov\u00e1","year":"2017","unstructured":"Matej\u010d\u00edkov\u00e1 Z, Mare\u0161 J, Sl\u00e1dkov\u00e1 V, et al. Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin. Mult Scler Relat Disord May. 2017;14:12\u20135. https:\/\/doi.org\/10.1016\/j.msard.2017.03.007.","journal-title":"Mult Scler Relat Disord May"},{"key":"4330_CR25","doi-asserted-by":"publisher","unstructured":"Breville G, Lascano AM, Roux-Lombard P, Vuilleumier N, Lalive PH. Interleukin 8, a Biomarker to Differentiate Guillain-Barr\u00e9 Syndrome From CIDP. Neurol Neuroimmunol Neuroinflamm Jul. 2021;8(5). https:\/\/doi.org\/10.1212\/nxi.0000000000001031.","DOI":"10.1212\/nxi.0000000000001031"},{"key":"4330_CR26","doi-asserted-by":"publisher","unstructured":"Pigo\u0144ska J, Pawe\u0142 W, Banach M. Neurophysiological and Ultrasound Correlations in Guillain Barr\u00e9 Syndrome and CIDP-Case Series. J Pers Med Jun. 2024;5(6). https:\/\/doi.org\/10.3390\/jpm14060603.","DOI":"10.3390\/jpm14060603"},{"issue":"3","key":"4330_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jnnp-2020-324445","volume":"92","author":"G Capodivento","year":"2021","unstructured":"Capodivento G, De Michelis C, Carpo M, et al. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS. J Neurol Neurosurg Psychiatry Mar. 2021;92(3):303\u201310. https:\/\/doi.org\/10.1136\/jnnp-2020-324445.","journal-title":"J Neurol Neurosurg Psychiatry Mar"},{"issue":"14","key":"4330_CR28","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"15","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer Jul. 2016;15(14):2158\u201367. https:\/\/doi.org\/10.1002\/cncr.30057.","journal-title":"Cancer Jul"},{"key":"4330_CR29","doi-asserted-by":"publisher","first-page":"1115031","DOI":"10.3389\/fimmu.2023.1115031","volume":"14","author":"RH Wang","year":"2023","unstructured":"Wang RH, Wen WX, Jiang ZP, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol. 2023;14:1115031. https:\/\/doi.org\/10.3389\/fimmu.2023.1115031.","journal-title":"Front Immunol"},{"key":"4330_CR30","doi-asserted-by":"publisher","unstructured":"Hu B, Yang XR, Xu Y et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. Dec 1. 2014;20(23):6212-22. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0442","DOI":"10.1158\/1078-0432.Ccr-14-0442"},{"issue":"10280","key":"4330_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/s0140-6736(21)00517-1","volume":"27","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet Mar. 2021;27(10280):1214\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(21)00517-1.","journal-title":"Lancet Mar"},{"key":"4330_CR32","doi-asserted-by":"publisher","first-page":"8821610","DOI":"10.1155\/2023\/8821610","volume":"2023","author":"Y Peng","year":"2023","unstructured":"Peng Y, Zhou M, Yang H, et al. Regulatory mechanism of M1\/M2 macrophage polarization in the development of autoimmune diseases. Mediators Inflamm. 2023;2023:8821610. https:\/\/doi.org\/10.1155\/2023\/8821610.","journal-title":"Mediators Inflamm"},{"issue":"9","key":"4330_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","volume":"16","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol Aug. 2011;16(9):507\u201317. https:\/\/doi.org\/10.1038\/nrneurol.2011.121.","journal-title":"Nat Rev Neurol Aug"},{"key":"4330_CR34","doi-asserted-by":"publisher","unstructured":"Akhter N, Wilson A, Thomas R, et al. ROS\/TNF-\u03b1 crosstalk triggers the expression of IL-8 and MCP-1 in human monocytic THP-1 cells via the NF-\u03baB and ERK1\/2 mediated signaling. Int J Mol Sci Sep. 2021;29(19). https:\/\/doi.org\/10.3390\/ijms221910519.","DOI":"10.3390\/ijms221910519"},{"issue":"22","key":"4330_CR35","doi-asserted-by":"publisher","first-page":"22538","DOI":"10.18632\/aging.103663","volume":"16","author":"L Xie","year":"2020","unstructured":"Xie L, Zhang N, Zhang Q, et al. Inflammatory factors and amyloid \u03b2-induced microglial polarization promote inflammatory crosstalk with astrocytes. Aging (Albany N Y). Nov. 2020;16(22):22538\u201349. https:\/\/doi.org\/10.18632\/aging.103663.","journal-title":"Nov"},{"issue":"2","key":"4330_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/eji.201948336","volume":"51","author":"A Hackel","year":"2021","unstructured":"Hackel A, Aksamit A, Bruderek K, Lang S, Brandau S. TNF-\u03b1 and IL-1\u03b2 sensitize human MSC for IFN-\u03b3 signaling and enhance neutrophil recruitment. Eur J Immunol Feb. 2021;51(2):319\u201330. https:\/\/doi.org\/10.1002\/eji.201948336.","journal-title":"Eur J Immunol Feb"},{"key":"4330_CR37","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.bbih.2022.100442","volume":"21","author":"K Diaz","year":"2022","unstructured":"Diaz K, Kohut ML, Russell DW, Stegem\u00f6ller EL. Peripheral inflammatory cytokines and motor symptoms in persons with parkinson\u2019s disease. Brain Behav Immun Health May. 2022;21:100442. https:\/\/doi.org\/10.1016\/j.bbih.2022.100442.","journal-title":"Brain Behav Immun Health May"},{"key":"4330_CR38","unstructured":"Kempuraj D, Thangavel R, Natteru PA et al. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine. 2016;1(1):1003."},{"issue":"11","key":"4330_CR39","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1007\/s00415-018-8994-5","volume":"265","author":"M Stampanoni Bassi","year":"2018","unstructured":"Stampanoni Bassi M, Iezzi E, Landi D, et al. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. J Neurol Nov. 2018;265(11):2540\u20137. https:\/\/doi.org\/10.1007\/s00415-018-8994-5.","journal-title":"J Neurol Nov"},{"issue":"11","key":"4330_CR40","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1080\/21645515.2018.1493415","volume":"14","author":"S Liu","year":"2018","unstructured":"Liu S, Dong C, Ubogu EE. Immunotherapy of Guillain-Barr\u00e9 syndrome. Hum Vaccin Immunother. 2018;14(11):2568\u201379. https:\/\/doi.org\/10.1080\/21645515.2018.1493415.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"4330_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.27046","volume":"63","author":"AM Stino","year":"2021","unstructured":"Stino AM, Naddaf E, Dyck PJ, Dyck PJB. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. Muscle Nerve Feb. 2021;63(2):157\u201369. https:\/\/doi.org\/10.1002\/mus.27046.","journal-title":"Muscle Nerve Feb"},{"issue":"8","key":"4330_CR42","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/s1474-4422(19)30144-9","volume":"18","author":"C Bunschoten","year":"2019","unstructured":"Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol Aug. 2019;18(8):784\u201394. https:\/\/doi.org\/10.1016\/s1474-4422(19)30144-9.","journal-title":"Lancet Neurol Aug"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04330-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T08:02:25Z","timestamp":1753948945000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04330-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4330"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04330-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Qilu Hospital of Shandong University granted permission to conduct the study (Approval No. KY-2020047). Informed consent to participate was obtained either from the patients or their next of kin. All the procedures were followed in accordance with the relevant guidelines (e.g. the Declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}